Intuitive Surgical, Inc. (NASDAQ:ISRG) Shares Purchased by Private Trust Co. NA

Private Trust Co. NA boosted its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 5.8% during the 4th quarter, Holdings Channel reports. The fund owned 1,014 shares of the medical equipment provider’s stock after acquiring an additional 56 shares during the quarter. Private Trust Co. NA’s holdings in Intuitive Surgical were worth $529,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other large investors have also recently added to or reduced their stakes in ISRG. Berbice Capital Management LLC acquired a new stake in Intuitive Surgical in the 4th quarter valued at approximately $26,000. BankPlus Trust Department acquired a new stake in Intuitive Surgical in the 4th quarter valued at approximately $28,000. MidAtlantic Capital Management Inc. bought a new position in Intuitive Surgical during the 3rd quarter valued at $33,000. Decker Retirement Planning Inc. bought a new position in Intuitive Surgical during the 4th quarter valued at $36,000. Finally, Capital Performance Advisors LLP bought a new position in Intuitive Surgical during the 3rd quarter valued at $38,000. 83.64% of the stock is currently owned by institutional investors and hedge funds.

Intuitive Surgical Stock Up 1.7 %

ISRG opened at $573.15 on Friday. The stock has a fifty day moving average of $569.87 and a 200-day moving average of $529.06. The firm has a market capitalization of $204.14 billion, a P/E ratio of 89.42, a PEG ratio of 5.85 and a beta of 1.39. Intuitive Surgical, Inc. has a 12-month low of $364.17 and a 12-month high of $616.00.

Insider Activity

In related news, CFO Jamie Samath sold 270 shares of the stock in a transaction on Tuesday, December 10th. The stock was sold at an average price of $540.15, for a total transaction of $145,840.50. Following the completion of the sale, the chief financial officer now directly owns 8,757 shares in the company, valued at approximately $4,730,093.55. This trade represents a 2.99 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, EVP Myriam Curet sold 2,401 shares of the stock in a transaction on Thursday, February 27th. The stock was sold at an average price of $581.00, for a total value of $1,394,981.00. Following the sale, the executive vice president now owns 353 shares of the company’s stock, valued at approximately $205,093. This represents a 87.18 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 8,077 shares of company stock worth $4,620,025 over the last quarter. Corporate insiders own 0.90% of the company’s stock.

Wall Street Analyst Weigh In

A number of equities analysts have issued reports on ISRG shares. Stifel Nicolaus increased their price target on Intuitive Surgical from $525.00 to $610.00 and gave the company a “buy” rating in a research note on Thursday, December 5th. CICC Research started coverage on Intuitive Surgical in a research note on Monday, January 27th. They set a “neutral” rating and a $550.00 price target for the company. Jefferies Financial Group increased their price target on Intuitive Surgical from $475.00 to $575.00 in a research note on Monday, January 27th. Royal Bank of Canada increased their price target on Intuitive Surgical from $611.00 to $641.00 in a research note on Monday, January 27th. Finally, BTIG Research increased their price target on Intuitive Surgical from $535.00 to $561.00 and gave the company a “buy” rating in a research note on Tuesday, November 26th. One equities research analyst has rated the stock with a sell rating, four have issued a hold rating and sixteen have issued a buy rating to the company. According to data from MarketBeat, the company presently has an average rating of “Moderate Buy” and an average price target of $613.10.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.